DiscoverThe Tell-Tale Heart: The Pharmacist's Cardiovascular Digest15: ESC 2025 Highlights: Insights on ALONE-AF and AQUATIC Trials
15: ESC 2025 Highlights: Insights on ALONE-AF and AQUATIC Trials

15: ESC 2025 Highlights: Insights on ALONE-AF and AQUATIC Trials

Update: 2025-09-09
Share

Description

Host Craig Beavers sits down with Lorenz van der Linden, a Belgian pharmacist, to dive deep into 2 groundbreaking trials from the European Society of Cardiology (ESC) 2025 Congress. They explore the ALONE-AF trial, which examined anticoagulation strategies for patients with atrial fibrillation after catheter ablation, and the AQUATIC trial, which investigated the role of aspirin in patients on oral anticoagulation. With their expert analysis, Craig and Lawrence break down the clinical implications, methodological nuances, and potential practice-changing insights from these important cardiovascular studies.



Show notes:




Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

15: ESC 2025 Highlights: Insights on ALONE-AF and AQUATIC Trials

15: ESC 2025 Highlights: Insights on ALONE-AF and AQUATIC Trials

The Tell-Tale Heart: The Pharmacist's Cardiovascular Digest